vs
Side-by-side financial comparison of Precipio, Inc. (PRPO) and SOLESENCE, INC. (SLSN). Click either name above to swap in a different company.
SOLESENCE, INC. is the larger business by last-quarter revenue ($12.5M vs $6.8M, roughly 1.8× Precipio, Inc.). Precipio, Inc. runs the higher net margin — 7.7% vs 1.3%, a 6.4% gap on every dollar of revenue. On growth, Precipio, Inc. posted the faster year-over-year revenue change (28.4% vs -0.7%). Over the past eight quarters, Precipio, Inc.'s revenue compounded faster (40.0% CAGR vs 12.5%).
Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.
PRPO vs SLSN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.8M | $12.5M |
| Net Profit | $526.0K | $163.0K |
| Gross Margin | 45.9% | 27.5% |
| Operating Margin | 7.9% | 1.5% |
| Net Margin | 7.7% | 1.3% |
| Revenue YoY | 28.4% | -0.7% |
| Net Profit YoY | 244.1% | 129.2% |
| EPS (diluted) | $0.36 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.8M | $12.5M | ||
| Q3 25 | $6.9M | $14.6M | ||
| Q2 25 | $5.6M | $20.4M | ||
| Q1 25 | $4.9M | $14.6M | ||
| Q4 24 | $5.3M | $12.6M | ||
| Q3 24 | $5.3M | $16.9M | ||
| Q2 24 | $4.5M | $13.0M | ||
| Q1 24 | $3.5M | $9.9M |
| Q4 25 | $526.0K | $163.0K | ||
| Q3 25 | $-79.0K | $-1.1M | ||
| Q2 25 | $74.0K | $2.7M | ||
| Q1 25 | $-884.0K | $80.0K | ||
| Q4 24 | $-365.0K | $-559.0K | ||
| Q3 24 | $-626.0K | $3.0M | ||
| Q2 24 | $-1.2M | $856.0K | ||
| Q1 24 | $-2.1M | $893.0K |
| Q4 25 | 45.9% | 27.5% | ||
| Q3 25 | 43.6% | 23.1% | ||
| Q2 25 | 43.2% | 28.9% | ||
| Q1 25 | 43.6% | 23.1% | ||
| Q4 24 | 49.8% | 22.0% | ||
| Q3 24 | 43.1% | 36.2% | ||
| Q2 24 | 38.1% | 28.7% | ||
| Q1 24 | 26.5% | 36.3% |
| Q4 25 | 7.9% | 1.5% | ||
| Q3 25 | -0.9% | -5.4% | ||
| Q2 25 | -14.6% | 9.4% | ||
| Q1 25 | -17.5% | 1.8% | ||
| Q4 24 | -6.3% | -1.8% | ||
| Q3 24 | -11.3% | 19.0% | ||
| Q2 24 | -26.8% | 8.0% | ||
| Q1 24 | -59.6% | 11.3% |
| Q4 25 | 7.7% | 1.3% | ||
| Q3 25 | -1.1% | -7.7% | ||
| Q2 25 | 1.3% | 13.1% | ||
| Q1 25 | -18.0% | 0.5% | ||
| Q4 24 | -6.9% | -4.4% | ||
| Q3 24 | -11.9% | 18.1% | ||
| Q2 24 | -27.1% | 6.6% | ||
| Q1 24 | -59.8% | 9.0% |
| Q4 25 | $0.36 | $0.00 | ||
| Q3 25 | $-0.05 | $-0.02 | ||
| Q2 25 | $0.05 | $0.04 | ||
| Q1 25 | $-0.59 | $0.00 | ||
| Q4 24 | $-0.22 | $0.00 | ||
| Q3 24 | $-0.42 | $0.04 | ||
| Q2 24 | $-0.83 | $0.01 | ||
| Q1 24 | $-1.46 | $0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.7M | $1.3M |
| Total DebtLower is stronger | $83.0K | — |
| Stockholders' EquityBook value | $14.6M | $17.6M |
| Total Assets | $21.3M | $50.1M |
| Debt / EquityLower = less leverage | 0.01× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.7M | $1.3M | ||
| Q3 25 | $2.3M | $429.0K | ||
| Q2 25 | $1.1M | $4.1M | ||
| Q1 25 | $1.0M | $1.8M | ||
| Q4 24 | $1.4M | $1.4M | ||
| Q3 24 | $1.1M | $2.9M | ||
| Q2 24 | $1.3M | $2.4M | ||
| Q1 24 | $776.0K | $2.0M |
| Q4 25 | $83.0K | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $383.0K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.6M | $17.6M | ||
| Q3 25 | $13.7M | $17.2M | ||
| Q2 25 | $12.3M | $18.2M | ||
| Q1 25 | $11.7M | $15.2M | ||
| Q4 24 | $12.1M | $14.9M | ||
| Q3 24 | $11.9M | $15.2M | ||
| Q2 24 | $12.1M | $11.9M | ||
| Q1 24 | $12.8M | $5.0M |
| Q4 25 | $21.3M | $50.1M | ||
| Q3 25 | $21.2M | $54.0M | ||
| Q2 25 | $18.8M | $60.0M | ||
| Q1 25 | $17.8M | $57.0M | ||
| Q4 24 | $17.0M | $50.0M | ||
| Q3 24 | $17.0M | $48.0M | ||
| Q2 24 | $17.3M | $40.8M | ||
| Q1 24 | $16.6M | $38.5M |
| Q4 25 | 0.01× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $366.0K | $1.8M |
| Free Cash FlowOCF − Capex | $291.0K | — |
| FCF MarginFCF / Revenue | 4.3% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | 0.70× | 11.16× |
| TTM Free Cash FlowTrailing 4 quarters | $359.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $366.0K | $1.8M | ||
| Q3 25 | $10.0K | $-2.5M | ||
| Q2 25 | $353.0K | $-654.0K | ||
| Q1 25 | $-44.0K | $-7.2M | ||
| Q4 24 | $565.0K | $2.2M | ||
| Q3 24 | $41.0K | $4.2M | ||
| Q2 24 | $500.0K | $-565.0K | ||
| Q1 24 | $-667.0K | $-3.9M |
| Q4 25 | $291.0K | — | ||
| Q3 25 | $-44.0K | — | ||
| Q2 25 | $294.0K | — | ||
| Q1 25 | $-182.0K | — | ||
| Q4 24 | — | $-404.0K | ||
| Q3 24 | $-68.0K | $2.8M | ||
| Q2 24 | — | $-1.0M | ||
| Q1 24 | — | $-3.9M |
| Q4 25 | 4.3% | — | ||
| Q3 25 | -0.6% | — | ||
| Q2 25 | 5.2% | — | ||
| Q1 25 | -3.7% | — | ||
| Q4 24 | — | -3.2% | ||
| Q3 24 | -1.3% | 16.6% | ||
| Q2 24 | — | -8.0% | ||
| Q1 24 | — | -39.9% |
| Q4 25 | 1.1% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | — | 20.6% | ||
| Q3 24 | 2.1% | 8.3% | ||
| Q2 24 | — | 3.7% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | 0.70× | 11.16× | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.77× | -0.25× | ||
| Q1 25 | — | -90.26× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.38× | ||
| Q2 24 | — | -0.66× | ||
| Q1 24 | — | -4.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
